Authors

Muhammad M Javaid

FRCP, FASN, FRACP, Adjunct Clinical Associate Professor, Rural Health Mildura, Monash University, Melbourne, Vic; Affiliate Associate Professor, School of Medicine, Deakin University, Warrnambool, Vic; Staff Specialist Nephrologist and Physician, South West Healthcare, Warrnambool, Vic

Sodium–glucose cotransporter 2 inhibitors for chronic kidney disease: Why, when and when not

This article aims to provide evidence-based information to GPs, aiding the decision to initiate sodium–glucose cotransporter 2 (SGLT2) inhibitors for chronic kidney disease patients.